Drug Shortage Report for LODALIS
| Report ID | 180700 |
| Drug Identification Number | 02373955 |
| Brand name | LODALIS |
| Common or Proper name | LODALIS |
| Company Name | BAUSCH HEALTH, CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | COLESEVELAM HYDROCHLORIDE |
| Strength(s) | 625MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 180s |
| ATC code | C10AC |
| ATC description | LIPID MODIFYING AGENTS, PLAIN |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2023-02-14 |
| Actual start date | 2023-01-31 |
| Estimated end date | 2023-03-10 |
| Actual end date | 2023-03-03 |
| Shortage status | Resolved |
| Updated date | 2023-03-04 |
| Company comments | waiting QA release |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v11 | 2023-03-04 | English | Compare |
| v10 | 2023-03-03 | French | Compare |
| v9 | 2023-03-03 | English | Compare |
| v8 | 2023-02-28 | French | Compare |
| v7 | 2023-02-28 | English | Compare |
| v6 | 2023-02-08 | French | Compare |
| v5 | 2023-02-08 | English | Compare |
| v4 | 2023-01-18 | French | Compare |
| v3 | 2023-01-18 | English | Compare |
| v2 | 2023-01-11 | French | Compare |
| v1 | 2023-01-11 | English | Compare |
Showing 1 to 11 of 11